Eli Lilly finds impurity in compounded tirzepatide
Eli Lilly has warned of high levels of an impurity in certain compounded versions of its blockbuster glucagon-like peptide-1 receptor…
News
Bavarian Nordic and SII sign agreement for chikungunya vaccine production
Curatis and Neupharma sign development agreement for corticorelin in Japan
FDA issues warning to Novo Nordisk on unreported semaglutide safety events
Eli Lilly to invest $3bn in China in anticipation of orforglipron approval
BioNTech co-founders step down to launch new mRNA venture
UK health authorities join forces to champion foreign infectious disease trials
Idorsia and Pharmalink sign agreement to distribute Quviviq
